MiR-492 exerts tumor-promoting function in prostate cancer through repressing SOCS2 expression.

CONCLUSIONS: This study demonstrated that miR-492 was over-expressed in PCa and exerted tumor-promoting function in PCa cells via repressing SOCS2 expression. This might provide a new sight for future accurate therapy for PCa. PMID: 30779065 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30779065?dopt=Abstract

Source: European Review for Medical and Pharmacological Sciences - February 21, 2019 Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research